Institutional Review Board Statement
ADVERSE EFFECTS
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of University E (EUIRB 2020-064). The study was conducted after registration with the Clinical Research Information Service (CRIS registered number: KCT0006654). The purpose of the study was explained in detail to all recruited participants before they agreed to participate. They were allowed to decide whether to participate or not. The consent form described the possibility of participation and withdrawal from the study, adverse effects, and how to cope with the adverse effects. It was explained that the collected data would be coded according to the personal data guidelines, used for approximately 1 year, and be permanently deleted after a storage period of 3 years. 